Canopy Growth Corporation Common Shares
$0.94
$0.02 (+2.56%)
$0.92Day Range$0.94
Key Statistics
Market Cap
$387.33M
Shares Outstanding
423.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Apr 7, 2014
Round Lot
100
Locale
US
Trading Data
Day Open
$0.93
Day High
$0.94
Day Low
$0.92
Volume
1.17M
VWAP
$0.93
Prev Close
$0.92
Transactions
--
Acc. Volume
--
About Canopy Growth Corporation Common Shares
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
MEDICINAL CHEMICALS & BOTANICAL PRODUCTSSIC 28331,128 employees1 HERSHEY DRIVE, SMITH FALLS, A6, K7A0A8855-558-9333IPO Apr 7, 2014US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001737927
- Composite FIGI
- BBG0069FB082
- Share Class FIGI
- BBG001T6MH82
- Ticker Root
- CGC
- SIC Code
- 2833
About Canopy Growth Corporation Common Shares (CGC) Stock
Canopy Growth Corporation Common Shares (CGC) closed the 2026-09-17 session at $0.94, up 2.56% versus the previous close (+0.02). The stock opened at $0.93 and traded between $0.92 and $0.94 during that session. Session trading volume was 1.2M shares. The volume-weighted average price (VWAP) is $0.93.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.
Canopy Growth Corporation Common Shares has a market capitalization of $387.3 million. The company operates in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS industry classification. CGC is listed on the XNAS exchange. The company employs approximately 1,128 people. Canopy Growth Corporation Common Shares is headquartered in SMITH FALLS, A6. The recorded listing date is 2014-04-07.
On this page you can find market CGC stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the MEDICINAL CHEMICALS & BOTANICAL PRODUCTS sector.